company background image
WGS logo

GeneDx Holdings NasdaqGS:WGS Stock Report

Last Price

US$9.46

Market Cap

US$246.5m

7D

11.2%

1Y

-3.3%

Updated

27 Mar, 2024

Data

Company Financials +

GeneDx Holdings Corp.

NasdaqGS:WGS Stock Report

Market Cap: US$246.5m

GeneDx Holdings Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeneDx Holdings
Historical stock prices
Current Share PriceUS$9.46
52 Week HighUS$12.24
52 Week LowUS$1.16
Beta2.8
1 Month Change16.36%
3 Month Change242.75%
1 Year Change-3.35%
3 Year Change-98.07%
5 Year Changen/a
Change since IPO-97.07%

Recent News & Updates

GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13

Feb 23
GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13

The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More

Feb 22
The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More

Recent updates

GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13

Feb 23
GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13

The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More

Feb 22
The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More

Improved Revenues Required Before GeneDx Holdings Corp. (NASDAQ:WGS) Stock's 56% Jump Looks Justified

Dec 20
Improved Revenues Required Before GeneDx Holdings Corp. (NASDAQ:WGS) Stock's 56% Jump Looks Justified

Analyst Forecasts Just Became More Bearish On GeneDx Holdings Corp. (NASDAQ:WGS)

Nov 02
Analyst Forecasts Just Became More Bearish On GeneDx Holdings Corp. (NASDAQ:WGS)

Not Many Are Piling Into GeneDx Holdings Corp. (NASDAQ:WGS) Stock Yet As It Plummets 49%

Nov 01
Not Many Are Piling Into GeneDx Holdings Corp. (NASDAQ:WGS) Stock Yet As It Plummets 49%

Sema4 names Kevin Feeley as CFO

Aug 26

Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade

Aug 20
Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade

Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Aug 19
Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Sema4 Q2 2022 Earnings Preview

Aug 12

Sema4 Holdings, Big Data For Precision Medicine Solutions

Jul 18

Shareholder Returns

WGSUS HealthcareUS Market
7D11.2%0.6%0.4%
1Y-3.3%9.5%28.8%

Return vs Industry: WGS underperformed the US Healthcare industry which returned 8.4% over the past year.

Return vs Market: WGS underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is WGS's price volatile compared to industry and market?
WGS volatility
WGS Average Weekly Movement22.0%
Healthcare Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: WGS's share price has been volatile over the past 3 months.

Volatility Over Time: WGS's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20171,000Katherine Stuelandhttps://www.genedx.com

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.

GeneDx Holdings Corp. Fundamentals Summary

How do GeneDx Holdings's earnings and revenue compare to its market cap?
WGS fundamental statistics
Market capUS$246.47m
Earnings (TTM)-US$175.77m
Revenue (TTM)US$202.57m

1.2x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WGS income statement (TTM)
RevenueUS$202.57m
Cost of RevenueUS$112.42m
Gross ProfitUS$90.15m
Other ExpensesUS$265.91m
Earnings-US$175.77m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-6.75
Gross Margin44.50%
Net Profit Margin-86.77%
Debt/Equity Ratio23.3%

How did WGS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.